The Scientist

» drug development and disease/medicine

Most Recent

image: Weak Support for Malaria Vaccine

Weak Support for Malaria Vaccine

By | October 27, 2015

The World Health Organization recommends more pilot trials.

0 Comments

image: Infection Assistants

Infection Assistants

By | October 22, 2015

Parasite-derived exosomes boost Leishmania infection in mice. 

0 Comments

image: Following FDA OK, 23andMe to Expand Health Prediction

Following FDA OK, 23andMe to Expand Health Prediction

By | October 21, 2015

The personal genomics firm is ramping up its suite of disease-related genetic tests.

0 Comments

image: Stem Cell Therapy In Utero

Stem Cell Therapy In Utero

By | October 13, 2015

An upcoming clinical trial aims to correct for a disease of fragile bones in affected babies before they are born.

0 Comments

image: Explaining Elephants’ Cancer Resistance

Explaining Elephants’ Cancer Resistance

By | October 13, 2015

Two studies reveal that the giant mammals have dozens of extra copies of a cancer-preventing gene.

0 Comments

image: Warming Up to Brown Fat

Warming Up to Brown Fat

By | October 8, 2015

Scientists know how to turn on these fat-combusting cells. Can these energy burners be used to combat obesity?

6 Comments

image: Phase 3 Win for Gene Therapy

Phase 3 Win for Gene Therapy

By | October 6, 2015

The treatment restored sight among people with an inherited visual impairment.

0 Comments

image: Gut Bacteria Linked to Asthma Risk

Gut Bacteria Linked to Asthma Risk

By | October 1, 2015

Four types of gut bacteria found in babies’ stool may help researchers predict the future development of asthma.

0 Comments

image: Seeing Things

Seeing Things

By | October 1, 2015

In Oliver Sacks's 2009 TED Talk, the famed physician and writer describes the neurological nature of hallucinations.

0 Comments

image: Biotech Stocks Take a Hit

Biotech Stocks Take a Hit

By | September 30, 2015

Some say the biotech bubble has burst over concerns that drug prices are too high—and may soon be regulated.

1 Comment

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech